Cite
HARVARD Citation
Guerreiro, M. et al. (2021). Adoptive transfer of ex vivo expanded SARS‐CoV‐2‐specific cytotoxic lymphocytes: A viable strategy for COVID‐19 immunosuppressed patients?. Transplant infectious disease. 23 (4), p. n/a. [Online].